Diligence memo · auto-generated · as of July 2, 2026
Parallax Health Sciences, Inc.
Parallax Health Sciences, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Parallax Health Sciences, Inc. operates in Healthtech, based in SANTA MONICA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Parallax Health Sciences, Inc. has raised $1.4M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $600K on 2018-06-18.
Most recent recorded round closed around 2018-11-16.
Valuation (modeled)modeled
Provath models Parallax Health Sciences, Inc. at approximately $8.6M (range $157K–$98M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.63× the median modeled value of Pre-Seed Healthtech companies in 2016–2018 (113 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 2 months.
Last raise 7.6 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 33% of Healthtech peers (2138 compared).
Modeled value ranks above 31% of those peers.
Closest niche peers: HealthTech Solutions, Inc., Nulogix Health, Inc., Caddo Medical Technologies LLC, Markit Medical, Inc., Unique Medical Services, LLC.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.